Cullinan Therapeutics, Inc. CGEM Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s other income, net (note 6)?
- Cullinan Therapeutics, Inc. (CGEM) reported other income, net (note 6) of -$62K in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s other income, net (note 6) changed year-over-year?
- Cullinan Therapeutics, Inc.'s other income, net (note 6) increased by 27.1% year-over-year, from -$85K to -$62K.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s other income, net (note 6)?
- Over 2 years (2022 to 2025), Cullinan Therapeutics, Inc.'s other income, net (note 6) has grown at a 178.8% compound annual growth rate (CAGR), from $57K to -$443K.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.